Published in Evol Med Public Health on December 21, 2014
The genomic basis of adaptation to the fitness cost of rifampicin resistance in Pseudomonas aeruginosa. Proc Biol Sci (2016) 0.80
Epistasis and the Evolution of Antimicrobial Resistance. Front Microbiol (2017) 0.76
Multidrug-resistant bacteria compensate for the epistasis between resistances. PLoS Biol (2017) 0.75
Reversing resistance: different routes and common themes across pathogens. Proc Biol Sci (2017) 0.75
Emergence of a new antibiotic resistance mechanism in India, Pakistan, and the UK: a molecular, biological, and epidemiological study. Lancet Infect Dis (2010) 35.92
Bacterial persistence as a phenotypic switch. Science (2004) 15.80
Antibacterial resistance worldwide: causes, challenges and responses. Nat Med (2004) 10.46
Effect of antibiotic prescribing in primary care on antimicrobial resistance in individual patients: systematic review and meta-analysis. BMJ (2010) 10.14
Rapid pneumococcal evolution in response to clinical interventions. Science (2011) 9.09
Genetic adaptation by Pseudomonas aeruginosa to the airways of cystic fibrosis patients. Proc Natl Acad Sci U S A (2006) 8.85
Seasonality of antibiotic-resistant streptococcus pneumoniae that causes acute otitis media: a clue for an antibiotic-restriction policy? J Infect Dis (2008) 7.76
Persistence of sulphonamide resistance in Escherichia coli in the UK despite national prescribing restriction. Lancet (2001) 6.37
Antibiotic resistance and its cost: is it possible to reverse resistance? Nat Rev Microbiol (2010) 6.18
Tracking the in vivo evolution of multidrug resistance in Staphylococcus aureus by whole-genome sequencing. Proc Natl Acad Sci U S A (2007) 6.14
Evolution of a bacteria/plasmid association. Nature (1988) 6.00
The competitive cost of antibiotic resistance in Mycobacterium tuberculosis. Science (2006) 5.41
Molecular mechanisms of antibacterial multidrug resistance. Cell (2007) 5.32
Antimicrobial pharmacodynamics: critical interactions of 'bug and drug'. Nat Rev Microbiol (2004) 5.19
The changing epidemiology of resistance. J Antimicrob Chemother (2009) 5.13
Compensatory mutations, antibiotic resistance and the population genetics of adaptive evolution in bacteria. Genetics (2000) 4.98
Parallel bacterial evolution within multiple patients identifies candidate pathogenicity genes. Nat Genet (2011) 4.81
Adaptation to the fitness costs of antibiotic resistance in Escherichia coli. Proc Biol Sci (1997) 4.55
Effects of environment on compensatory mutations to ameliorate costs of antibiotic resistance. Science (2000) 4.48
Reducing antibiotic resistance. Nature (1996) 3.57
The epidemiology of antibiotic resistance in hospitals: paradoxes and prescriptions. Proc Natl Acad Sci U S A (2000) 3.56
Whole-genome sequencing of rifampicin-resistant Mycobacterium tuberculosis strains identifies compensatory mutations in RNA polymerase genes. Nat Genet (2011) 3.44
Dynamic persistence of antibiotic-stressed mycobacteria. Science (2013) 3.34
Evolutionary dynamics of Staphylococcus aureus during progression from carriage to disease. Proc Natl Acad Sci U S A (2012) 3.29
The biological cost of mutational antibiotic resistance: any practical conclusions? Curr Opin Microbiol (2006) 3.19
Microbial cell individuality and the underlying sources of heterogeneity. Nat Rev Microbiol (2006) 3.18
Long-term persistence of resistant Enterococcus species after antibiotics to eradicate Helicobacter pylori. Ann Intern Med (2003) 3.04
Biological cost and compensatory evolution in fusidic acid-resistant Staphylococcus aureus. Mol Microbiol (2001) 2.94
Plasmids and the spread of resistance. Int J Med Microbiol (2013) 2.33
Compensatory adaptation to the deleterious effect of antibiotic resistance in Salmonella typhimurium. Mol Microbiol (2002) 2.32
Adaptation to the deleterious effects of antimicrobial drug resistance mutations by compensatory evolution. Res Microbiol (2004) 2.23
Effect of antibiotic prescribing on antibiotic resistance in individual children in primary care: prospective cohort study. BMJ (2007) 2.19
Population biological principles of drug-resistance evolution in infectious diseases. Lancet Infect Dis (2011) 2.11
Genome sequencing of 161 Mycobacterium tuberculosis isolates from China identifies genes and intergenic regions associated with drug resistance. Nat Genet (2013) 1.95
Genomic analysis identifies targets of convergent positive selection in drug-resistant Mycobacterium tuberculosis. Nat Genet (2013) 1.93
Genome analysis of a transmissible lineage of pseudomonas aeruginosa reveals pathoadaptive mutations and distinct evolutionary paths of hypermutators. PLoS Genet (2013) 1.64
Enhancement of host fitness by the sul2-coding plasmid p9123 in the absence of selective pressure. J Antimicrob Chemother (2004) 1.58
The population genetics of antibiotic resistance: integrating molecular mechanisms and treatment contexts. Nat Rev Genet (2010) 1.58
Mutation Rate Inferred From Synonymous Substitutions in a Long-Term Evolution Experiment With Escherichia coli. G3 (Bethesda) (2011) 1.53
Exploring the costs of horizontal gene transfer. Trends Ecol Evol (2013) 1.53
Little evidence for reversibility of trimethoprim resistance after a drastic reduction in trimethoprim use. J Antimicrob Chemother (2009) 1.51
The social evolution of bacterial pathogenesis. Proc Biol Sci (2001) 1.51
A systematic review and meta-analysis of the effects of antibiotic consumption on antibiotic resistance. BMC Infect Dis (2014) 1.46
Seasonality and temporal correlation between community antibiotic use and resistance in the United States. Clin Infect Dis (2012) 1.43
Fitness cost of VanA-type vancomycin resistance in methicillin-resistant Staphylococcus aureus. Antimicrob Agents Chemother (2009) 1.38
Putative compensatory mutations in the rpoC gene of rifampin-resistant Mycobacterium tuberculosis are associated with ongoing transmission. Antimicrob Agents Chemother (2012) 1.31
Fitness-compensatory mutations in rifampicin-resistant RNA polymerase. Mol Microbiol (2012) 1.29
Reversion to susceptibility in a linezolid-resistant clinical isolate of Staphylococcus aureus. J Antimicrob Chemother (2004) 1.28
Plasmid-mediated horizontal gene transfer is a coevolutionary process. Trends Microbiol (2012) 1.22
Persistence: mechanisms for triggering and enhancing phenotypic variability. Curr Opin Genet Dev (2011) 1.22
Positive selection and compensatory adaptation interact to stabilize non-transmissible plasmids. Nat Commun (2014) 1.16
A genome-wide analysis of promoter-mediated phenotypic noise in Escherichia coli. PLoS Genet (2012) 1.14
Nitrofurantoin resistance mechanism and fitness cost in Escherichia coli. J Antimicrob Chemother (2008) 1.13
Comparison of fitness of two isolates of Mycobacterium tuberculosis, one of which had developed multi-drug resistance during the course of treatment. J Infect (2000) 1.11
Mutational neighbourhood and mutation supply rate constrain adaptation in Pseudomonas aeruginosa. Proc Biol Sci (2009) 1.10
Contribution of phenotypic heterogeneity to adaptive antibiotic resistance. Proc Natl Acad Sci U S A (2013) 1.07
Mycobacterial mistranslation is necessary and sufficient for rifampicin phenotypic resistance. Proc Natl Acad Sci U S A (2014) 1.05
Multiple drug-resistant Mycobacterium tuberculosis: evidence for changing fitness following passage through human hosts. Microb Drug Resist (2002) 1.02
Compensation of fitness costs and reversibility of antibiotic resistance mutations. Antimicrob Agents Chemother (2010) 1.01
Restored fitness leads to long-term persistence of resistant Bacteroides strains in the human intestine. Anaerobe (2008) 0.98
Effect of multidrug resistance-conferring mutations on the fitness and virulence of Pseudomonas aeruginosa. J Antimicrob Chemother (2011) 0.97
Colonization dynamics of ampicillin-resistant Escherichia coli in the infantile colonic microbiota. J Antimicrob Chemother (2008) 0.96
Mapping the fitness of Mycobacterium tuberculosis strains: a complex picture. J Med Microbiol (2010) 0.96
The genetic basis of the fitness costs of antimicrobial resistance: a meta-analysis approach. Evol Appl (2014) 0.95
Fitness of Mycobacterium tuberculosis strains of the W-Beijing and Non-W-Beijing genotype. PLoS One (2010) 0.93
Pre-disposition and epigenetics govern variation in bacterial survival upon stress. PLoS Genet (2012) 0.90
Estimating fitness by competition assays between drug susceptible and resistant Mycobacterium tuberculosis of predominant lineages in Mumbai, India. PLoS One (2012) 0.88
Fitness cost: a bacteriological explanation for the demise of the first international methicillin-resistant Staphylococcus aureus epidemic. J Antimicrob Chemother (2012) 0.88
Escaping an evolutionary lobster trap: drug resistance and compensatory mutation in a fluctuating environment. Evolution (2011) 0.86
Testing the role of genetic background in parallel evolution using the comparative experimental evolution of antibiotic resistance. Mol Biol Evol (2014) 0.85
Antibiotic resistance in Pseudomonas aeruginosa is associated with decreased fitness. Cell Physiol Biochem (2013) 0.84
Evolutionary reversals of antibiotic resistance in experimental populations of Pseudomonas aeruginosa. Evolution (2013) 0.83
When is an outbreak not an outbreak? Fit, divergent strains of Mycobacterium tuberculosis display independent evolution of drug resistance in a large London outbreak. J Antimicrob Chemother (2012) 0.80
Metallo-β-lactamase expression confers an advantage to Pseudomonas aeruginosa isolates compared with other β-lactam resistance mechanisms, favoring the prevalence of metallo-β-lactamase producers in a clinical environment. Microb Drug Resist (2010) 0.78